These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12798571)

  • 1. Preserved endothelial function after long-term eccentric isosorbide mononitrate despite moderate nitrate tolerance.
    Müller S; Laber U; Müllenheim J; Meyer W; Kojda G
    J Am Coll Cardiol; 2003 Jun; 41(11):1994-2000. PubMed ID: 12798571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of vascular oxidative stress in hypercholesterolemia by eccentric isosorbide mononitrate.
    Müller S; König I; Meyer W; Kojda G
    J Am Coll Cardiol; 2004 Aug; 44(3):624-31. PubMed ID: 15358031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo effects of pentaerythrityl-tetranitrate and isosorbide-5-mononitrate on the development of atherosclerosis and endothelial dysfunction in cholesterol-fed rabbits.
    Kojda G; Stein D; Kottenberg E; Schnaith EM; Noack E
    J Cardiovasc Pharmacol; 1995 May; 25(5):763-73. PubMed ID: 7543171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerance to nitroglycerin induced by isosorbide-5-mononitrate infusion in vivo.
    Manabe T; Yamamoto A; Satoh K; Ichihara K
    Biol Pharm Bull; 2001 Dec; 24(12):1370-2. PubMed ID: 11767104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic therapy with isosorbide-5-mononitrate causes endothelial dysfunction, oxidative stress, and a marked increase in vascular endothelin-1 expression.
    Oelze M; Knorr M; Kröller-Schön S; Kossmann S; Gottschlich A; Rümmler R; Schuff A; Daub S; Doppler C; Kleinert H; Gori T; Daiber A; Münzel T
    Eur Heart J; 2013 Nov; 34(41):3206-16. PubMed ID: 22555214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term isosorbide mononitrate treatment impairs endothelial function in patients with coronary artery disease.
    Lai J; Wu B; Sun J; Shang Y; Zhu J
    Coron Artery Dis; 2013 Nov; 24(7):566-71. PubMed ID: 23994882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amelioration of nitrate tolerance: matching strategies with mechanisms.
    Horowitz JD
    J Am Coll Cardiol; 2003 Jun; 41(11):2001-3. PubMed ID: 12798572
    [No Abstract]   [Full Text] [Related]  

  • 8. The Endothelin Receptor Antagonist Macitentan Improves Isosorbide-5-Mononitrate (ISMN) and Isosorbide Dinitrate (ISDN) Induced Endothelial Dysfunction, Oxidative Stress, and Vascular Inflammation.
    Steven S; Oelze M; Hausding M; Roohani S; Kashani F; Kröller-Schön S; Helmstädter J; Jansen T; Baum C; Iglarz M; Schulz E; Münzel T; Daiber A
    Oxid Med Cell Longev; 2018; 2018():7845629. PubMed ID: 30687454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 5-isosorbide mononitrate on isosorbide dinitrate-induced relaxation of rabbit aortic rings.
    Bennett BM; Tam GS; Van Alstyne K; Brien JF; Nakatsu K; Marks GS
    Can J Physiol Pharmacol; 1984 Sep; 62(9):1194-7. PubMed ID: 6498631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of controlled-release isosorbide-5-mononitrate in Japanese patients with stable effort angina pectoris.
    Shimada K; Sunayama S; Nakazato K; Satoh H; Kusama Y; Kawakubo K; Daida H
    Int Heart J; 2006 Sep; 47(5):695-705. PubMed ID: 17106140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nonintermittent treatment of rabbits with pentaerythritol tetranitrate on vascular reactivity and superoxide production.
    Kojda G; Hacker A; Noack E
    Eur J Pharmacol; 1998 Aug; 355(1):23-31. PubMed ID: 9754935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of oral route isosorbide 5-mononitrate on peritoneal solute and fluid transports in CAPD patients.
    Kanjanabuch T; Eiam-Ong S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S129-37. PubMed ID: 17044464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preservation of platelet responsiveness to nitroglycerine despite development of vascular nitrate tolerance.
    Holmes AS; Chirkov YY; Willoughby SR; Poropat S; Pereira J; Horowitz JD
    Br J Clin Pharmacol; 2005 Oct; 60(4):355-63. PubMed ID: 16187967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isosorbide mononitrate 30% immediate-release 70% sustained-release formulation: a review. DUMQOL (DUtch Mononitrate Quality of Life) Study Group.
    Cleophas TJ; Niemeyer MG; Zwinderman AH; van der Wall EE
    Angiology; 2000 Aug; 51(8):631-8. PubMed ID: 10959515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oral organic nitrates on expression and activity of vascular soluble guanylyl cyclase.
    Oppermann M; Dao VT; Suvorava T; Bas M; Kojda G
    Br J Pharmacol; 2008 Oct; 155(3):335-42. PubMed ID: 18587420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular dysfunction in experimental diabetes is improved by pentaerithrityl tetranitrate but not isosorbide-5-mononitrate therapy.
    Schuhmacher S; Oelze M; Bollmann F; Kleinert H; Otto C; Heeren T; Steven S; Hausding M; Knorr M; Pautz A; Reifenberg K; Schulz E; Gori T; Wenzel P; Münzel T; Daiber A
    Diabetes; 2011 Oct; 60(10):2608-16. PubMed ID: 21844097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma profile and haemodynamic tolerance to isosorbide-5-mononitrate in controlled-release form.
    Jähnchen E
    Br J Clin Pharmacol; 1992; 34 Suppl 1(Suppl 1):15S-17S. PubMed ID: 1633073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effectiveness of extended-release nitrate for the treatment of systolic hypertension.
    Stokes GS; Bune AJ; Huon N; Barin ES
    Hypertension; 2005 Mar; 45(3):380-4. PubMed ID: 15699445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low doses of isosorbide mononitrate attenuate the postprandial increase in portal pressure in patients with cirrhosis.
    Bellis L; Berzigotti A; Abraldes JG; Moitinho E; García-Pagán JC; Bosch J; Rodés J
    Hepatology; 2003 Feb; 37(2):378-84. PubMed ID: 12540788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organic nitrates: update on mechanisms underlying vasodilation, tolerance and endothelial dysfunction.
    Münzel T; Steven S; Daiber A
    Vascul Pharmacol; 2014 Dec; 63(3):105-13. PubMed ID: 25446162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.